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Peter Norsk
Abstract
There are eight steps in the preparation, implementation and execution of 
a human spaceflight experiment: (1) writing a proposal, (2) being selected by 
a space agency, (3) finding funding, (4) flight feasibility assessment for flight, 
(5) implementation into a specific space platform (e.g. the Space Shuttle in the past 
and now the International Space Station), (6) experiment execution, (7) analysis 
of collected data and (8) publication. The unique features about spaceflight experi-
ments are steps 4–6 because of the limitations of conducting experimental proce-
dures in space. Furthermore, all of the associated equipment have to be developed 
and approved for spaceflight with all the safety aspects taken appropriately into 
consideration. In this chapter, two specific experiments from the Spacelab D2 
mission in 1993 are used as illustration of these steps as well as describing the use 
of parabolic flights as a preparatory platform. It is important to have data collected 
of such a quality that they can be published in science journals with external peer 
review. It is also important that the data not only have operational spaceflight 
applications but also can advance knowledge for terrestrial science purposes.
Keywords: cardiac output, cardiovascular, central venous pressure, parabolic flight, 
weightlessness
1. Introduction
On 22 March 1993, I was closely watching the big screen in the German Space 
Control Centre in Oberpfaffenhofen near Munich, Germany. The Space Shuttle with 
the Spacelab D2 mission was just about to lift off, and on board were seven astro-
nauts and equipment for a host of experiments of which four were from Denmark. 
I was the responsible investigator for these four experiments. I was nervous. In 
the airplane from Copenhagen to Munich the day before, I had told myself that 
this would either be my stepping stone to a further career in space physiology and 
medicine or simply my big Waterloo. The Danish government had payed millions of 
Kroners in preparation of the studies, and failure was not an option. The problem, 
though, was that anything random, which was totally out of my and my colleagues’ 
control, could happen at any time and jeopardise our experiments.
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The four experiments had been under preparation for some 5 years and sup-
ported by Danish space research grants. Eight people had been full time involved 
in my laboratory: four engineers and four medical doctors. Equipment had been 
developed, tested and adapted for spaceflight, and many nervous moments had 
been overcome. It was exciting times and now—finally—everything was about to 
be launched into space to orbit the Earth at a speed of 28,000 km per hour in a free 
fall condition inducing chronic weightlessness for 10 days. I felt tense as the launch 
countdown approached zero.
A few seconds before launch, two of the three Space Shuttle engines ignited. 
The third one did not. Immediately we knew in the control room that something 
was wrong. One of the engines did not blast, and within a few seconds, all engines 
stopped. As water vapour evaporated away from the shuttle, we waited anxiously. 
What would happen now?
The ignition had failed, and within the next hour or so, the astronauts were let 
out, and the launch postponed until the end of April. In that interim period, we had 
to repeat some ground tests on the astronauts in collaboration with several other 
international teams from Europe and the United States. Finally, after some addi-
tional postponements of the launch, the Space Shuttle Columbia ignited on 26 April 
and went to space, where it completed a 10-day mission with great success. Almost 
90 experiments were expertly conducted. Concerning the four Danish human 
physiology experiments, the data were successfully collected, which 2–3 years later 
led to three scientific papers [1–3] from our Danish space medicine and physiology 
laboratory, DAMEC Research Inc. (Danish Aerospace Medical Centre of Research 
Inc.), at the Copenhagen University Hospital.
The successful completion of our experiments on the Spacelab D2 mission in 
1993 with the publications in 1995 and 1996 led to the later expert preparation, 
implementation and conduction of seven additional studies in space on the Russian 
Mir station, Space Shuttle Columbia and International Space Station. All studies 
had cardiovascular adaptation aspects, and parabolic flights were used—not only 
for preparation of the spaceflight experiments but also to obtain basic science 
knowledge of human physiological responses to very acute weightlessness of 20 s.
2. Experimental science background
During changes in posture, blood pressure in humans is continuously and 
acutely regulated by pressure reflexes originating from receptors (baroreceptors) in 
the aorta close to the heart and in the two carotid (neck) arteries at the base of the 
skull. In addition, there are pressure sensors in the heart, from which reflexes also 
originate to participate in blood pressure control. This blood pressure regulation 
is for the central nervous system to make sure that the perfusion pressures to the 
brain and other organs are optimal despite the displacement of blood caused by the 
posture. As an example, the upright posture displaces blood downwards towards 
the lower body and the legs away from the head and heart. To counteract that so 
that the blood pressure at heart and head level does not fall too much, which would 
impede blood supply to the brain, the blood pressure reflexes sense the decrease in 
pressure and within a few heart beats initiate an increase in heart rate and constric-
tion of the small arteries in the lower body. The opposite occurs, when the posture 
changes from upright to recumbent or supine.
We have for many years investigated, which blood pressure sensors are the 
most important for adjusting blood pressure to posture changes. In a whole host of 
investigations using a combination of various models as well as short-term weight-
lessness during parabolic flights, we have aimed at isolating the effects of some 
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receptors versus others and found that in order for blood pressure and heart rate to 
adapt to either the supine or upright posture, the low pressure reflexes originating 
from the heart and major central veins are pivotal. Without the inputs from these 
low pressure heart and venous reflexes, the new steady state cannot be achieved. 
These findings have changed our previous understanding of how the human cardio-
vascular system adapts to changes in postures and the effects of gravity.
Since blood pressure is also determined by the amount of fluid in the body, we 
have used the human head-out water immersion model to investigate how the vol-
ume of fluid and amount of salt is controlled. By immersing humans in the seated 
posture to the level of the neck for hours, the fluid- and salt-excreting mechanisms 
through the kidneys are stimulated, because the headward shift of blood and fluid 
from the lower body to the heart through various mechanisms informs the central 
nervous system that the upper body vessels are being overloaded with blood and 
fluid so that this excess volume must be excreted. The mechanisms for this are still 
only partly understood, but the main opinion is that there is a connection between 
the heart and kidneys through what is termed the cardio-renal link so that when the 
heart chambers are stretched, it initiates a reflex response to the kidneys to excrete 
more salt and fluid in the urine.
Our research using the seated head-out water immersion model has shown that 
not only the cardio-renal link and associated hormones control the urinary excretion 
rates of sodium during shifting of blood and fluid to the upper body but also dilu-
tion of the blood with fluid from the tissues plays an important role. During shift of 
blood from the lower to the upper body caused by the surrounding water pressure, 
fluid is pushed into the circulation from the lower body tissues. This dilution can 
affect the kidneys directly as well as release of some kidney-regulating hormones.
Weightlessness in space is a unique condition that cannot be replicated on the 
ground and where bodily functions can be studied without the intervening effects 
of gravity. In space, blood and fluids are chronically displaced towards the upper 
body segments (heart and head), and the daily fluctuations induced by posture 
changes do not occur. This gives us a unique opportunity to utilise weightlessness in 
space for exploring the cardiovascular and fluid volume-regulating systems in the 
human body.
3. Experiments: the spacelab D2 mission in 1993
The experiments on the Spacelab D2 mission in 1993 aimed at understanding 
whether the blood and fluid shift into the heart during prolonged weightlessness 
would augment the urinary output of water and salt, just as we usually observe in 
ground-based simulation models. In one experiment we aimed at measuring how 
much the fluid pressure leading into the heart (central venous pressure, CVP) 
increases, which we at that time thought to be the stimulus for control of the 
urinary fluid and salt excretion. In another experiment we aimed at monitoring the 
urine production. It was the hypothesis that an increase in CVP induced by weight-
lessness would augment the excretion rate of fluid and salt.
3.1 CVP experiment
The CVP experiment was originally planned to be done on two of the Spacelab 
D2 astronauts, but for some technical reasons, it was only accomplished in one. 
The experimental plan was to shortly before launch insert a long catheter with a 
pressure transducer at the end into the vein directly leading into the right atrial 
chamber of the heart through a peripheral arm vein and connect it to a preamplifier 
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and a recording system. The test astronaut would thus be inserted with the catheter 
and wear the CVP monitoring system until 3 hours into the mission following 
launch. Thereafter the catheter would be withdrawn. Before the launch of the Space 
Shuttle, control measurements in different body postures were performed.
The equipment used for measurements of central venous pressure during the 
Spacelab D2 mission in one astronaut is depicted in Figure 1. The central venous 
catheter (1) with a pressure transducer placed at one end and a connector box at 
the other was plugged into a preamplifier (2) that was connected to a recording 
unit (3). A calibration piston (4) could be connected to the reference opening of 
the catheter and thus induce predetermined pressure changes on the backside of 
the transducer membrane. In this way, it was tested to what degree the calibration 
characteristics of the pressure transducer might have changed over time after being 
inserted into the astronaut. Following the spaceflight, the catheter was brought 
back to the investigators and tested for change in drift of the tip transducer.
3.2 Urinary excretion experiment
Before the spaceflight, four test astronauts would, over a 4.5-h period, empty 
their urine bladders in either supine or seated posture, on an hourly basis after 
being infused through a peripheral vein with isotonic saline in an amount of 2% of 
their body weight. About a week into the flight, the same would be done following 
a similar infusion while they thus would be free floating in the space vehicle. Blood 
was sampled on ground and during flight for determination of water-, salt- and 
blood pressure-regulating hormones. The volume of urine was measured after 
each void and samples taken for determination of salt (sodium and potassium) 
concentrations. In space, the volume of urine was determined by a urine monitoring 
system delivered by NASA, which was connected to the toilet. If the voids were felt 
by the subjects to be small, the bladders were emptied into bags and returned to 
Figure 1. 
Central venous pressure equipment, which flew on the Spacelab D2 mission in 1993 [3]. (See text for detailed 
explanation).
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Earth through the trash system on the Shuttle. The saline infusion was conducted 
over some 20 min by manually inflating a cuff-pressure system, and the amount 
varied on an average between 1.7 and 1.8 litres.
4. Experiments during subsequent missions (1995–2012)
After the Spacelab D2 mission in 1993, our research team in Denmark conducted 
additional experiments on various space platforms with one on the Russian space 
station, Mir, in 1995, where we monitored urine excretion rates over longer flight 
periods of up to 6 months by having three test astronauts collect urine into bags and 
the volumes measured by a scale system. The idea was to test whether urine produc-
tion in weightlessness after intake of an oral water load would be enhanced—just 
like we tested the same hypothesis regarding urinary salt excretion on the previous 
Spacelab D2 mission.
During later space missions, we have conducted several additional studies on the 
Space Shuttle and the International Space Station focusing on the cardiovascular 
adaptation to short (<30 days) and long (>30 days) duration flights. In particular, 
we have for this purpose conducted cardiac output measurements by a non-invasive 
rebreathing technique, which has been developed for spaceflight. Cardiac output is 
the amount of blood injected by the heart into the body per minute, and this vari-
able is important for understanding the effects of weightlessness on not only cardiac 
function but also the vascular condition in general. The hypothesis was tested that 
the weightlessness-induced increase in central blood volume would increase cardiac 
output and at the same time through the cardiovascular reflexes dilate the arterial 
resistance vessels to counteract an increase in blood pressure.
Normally, accurate cardiac output estimations require insertion of catheters into 
the veins and arteries, which makes the measurement difficult on a routine basis in 
normal healthy humans. With the non-invasive foreign gas rebreathing technique 
developed for spaceflight, such estimations can be done anytime and anywhere 
with no harm to the test subject. As indicated in Figure 2, the tested person breathes 
Figure 2. 
The principle of foreign gas rebreathing for measurement of cardiac output [4]. (See text for explanation).
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back and forth into a rebreathing bag with a gas mixture, in which a tracer gas (e.g. 
N2O) is taken up by the blood flowing through the lungs. The disappearance rate of 
the tracer gas from the lungs to blood is detected by an infrared photoacoustic gas 
analyser connected to the mouthpiece of the rebreathing person. By knowing the 
solubility of the gas in the blood, the amount of blood flowing through the lungs per 
unit of time can be calculated. This amount is equal to cardiac output. The measure-
ments take less than 30 s and are pivotal for understanding how cardiac output 
adapts to various conditions such as weightlessness in space [4].
This methodology is currently being used on the International Space Station for 
various research projects and has been developed from a mass spectrometry detec-
tion technique for measuring gas concentrations to using infrared photoacoustic 
gas detection. This has made it possible to have a much less voluminous and more 
user-friendly equipment on board the space station. Also, this technique has been 
tested against golden standard invasive clinical techniques, where excellent correla-
tions have been found [5].
5. Microgravity experiment implementation and execution
The cardiovascular experiments that we have conducted in space through the 
past three decades entail the following steps: (1) proposal, (2) selection, (3) fund-
ing, (4) feasibility assessment, (5) implementation, (6) execution, (7) data analysis 
and (8) publication. The unique features about spaceflight experiments are steps 
4–6, because of the limitations of conducting experimental procedures in space. 
Furthermore, all of the associated equipment have to be developed and approved 
for spaceflight with all the safety aspects taken appropriately into consideration.
5.1 Proposal
The first step for performing experiments in space is to develop a proposal and 
respond to a space agency solicitation from, e.g. the European Space Agency (ESA) 
or National Aeronautics and Space Administration (NASA). ESA’s topics are usually 
broader than NASA’s, because the latter are mostly focused on operational aspects. 
In both cases the proposal formats are rather similar and the subsequent selection 
process very much like the way it is done at the national levels with peer review 
panels and scientific merit scorings. In order for a proposal to be successful, the 
following criteria must generally be fulfilled:
1. Qualified research team with experimental experience from a university or a 
recognised company. Most proposals are from universities, and experience in 
space research is an advantage but not a requirement.
2. Clearly written proposal, which fulfils the requirements stated in the call.
3. Adherence to all of the rules and instructions—otherwise the proposals will 
be rejected upon receipt, and this includes adhering to the stated deadlines for 
submission.
4. Relevancy for utilising spaceflight meaning that what is proposed to be mea-
sured should be responsive to the flight environment (e.g. weightlessness).
One thing to keep in mind when writing a proposal is to formulate it so that 
non-experts in the field can also get something meaningful out of it, because at the 
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time of selection and thereafter, decision-makers who may not be scientists might 
make a judgement as to the appropriateness of spending resources in space for this 
particular experiment.
5.2 Selection
When a proposal is submitted in response to a research announcement, the 
first step is that it will be evaluated by scientists appointed by the space agency or 
a group of space agencies. The scientists—or peer reviewers—are usually experts 
within the field of the topic of the solicitation, who are not involved in collabora-
tions with the proposers. The peer review panels are usually led by an agency 
representative, and the panel will score each proposal on a scale between zero and 
100. Scores between 90 and 100 are categorised as “Excellent” or “Outstanding”, 
80 and 89 as “Very Good”, 70 and 79 as “Good”, 50 and 69 as “Fair” and below 50 
as “Poor”. The score threshold for selection may vary between space agencies, but 
usually no proposals are selected with a score lower than 70.
The next step for the space agency representatives is to—based on the peer 
review scores—perform final selections. In this case, not only the scientific merit 
scores play a role but also the relevancy of the proposal for the agency. Usually a 
subset of the highest scientifically scoring proposals are selected, but sometimes 
even proposals with the highest scores may not be finally selected because of less 
relevancy for the operational purposes of the agency. In this regard, there are dif-
ferent policies between the space agencies. For NASA, deep space explorations are 
the main drivers, while ESA usually focuses almost entirely on the scientific merit 
and the proposal’s ability to produce new fundamental knowledge to the scientific 
community.
5.3 Funding
In order for a selected proposal to be executed in space, funding has to be 
obtained. This can either be done by grants from local and national authorities or 
from the space agency itself. The problem in particular for European researchers is 
that for ESA to consider selection of a proposal, it is advantageous to have obtained 
national funding or a declaration of intention of funding already before submission. 
In many cases, national authorities will only indicate intention of funding, should 
the proposal be selected, but they usually will not guarantee it. This can sometimes 
create a hen and an egg problem: The space agency will—before it actually finally 
selects a proposal—require guaranteed funding from a national authority, whereas 
the national authority requires that the agency selects the proposal. The proposers 
usually obtain intention for funding in letters from the national funding authorities, 
and usually the space agency will accept that. In our case, when the research team 
was supported for selected experiments, we referred to an existing grant that could 
overlap with selection of a new proposal.
Funding of a grant for experiments in space usually only covers the expenses 
incurred by the experimental research team. The space infrastructure, such as 
access to a space vehicle and its astronauts (e.g. the Space Shuttle), is delivered by 
the space agencies.
5.4 Feasibility
When selection and funding are obtained, the space agency will conduct a 
feasibility study to evaluate whether the experiment can be implemented in space 
and whether there are technical or other obstacles. If these cannot be overcome, 
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the proposal will be de-selected. Usually the experiment is modified, if obstacles 
are detected. An obstacle for implementation may not just be technical such as 
lack of availability of a technique or equipment but may also be lack of astronaut 
crew time for execution of the experiment. In that case, the experiment is usually 
modified in close collaboration with the research team. If the experiment changes 
considerably, the space agency may require an additional scientific peer review to 
evaluate whether the scientific quality is still high enough, but this is not the usual 
process.
5.5 Implementation
When the space agency feasibility assessment has been successfully completed, 
meaning that the experiment can be conducted in space, the implementation pro-
cess begins. All of our previous research team’s selected experiments (10 in total) 
have been somehow modified during the feasibility assessment and implementation 
processes. The renal experiment on the Spacelab D2 mission in 1993 was changed by 
decreasing the number of inflight sessions from two to one, because of limited crew 
time. The purpose was as previously described to evaluate the effects of applying an 
intravenous saline fluid load to the test astronauts on renal excretion rates of fluid 
and sodium. We had originally planned a session with infusion and a session with-
out, but only the infusion session could be implemented in space. Otherwise the 
experiment was kept intact except that it was actually improved by changing our 
proposed saline loading from an oral saltwater load to intravenous infusion. This 
was done because an experimental complement was created for the space mission, 
whereby several experiments were to be executed in an integrated fashion, and a US 
experiment had suggested to use saline loading by infusion. Thus, this intravenous 
infusion of isotonic saline was planned to be done for the first time ever in space.
Although the urinary experiment was not difficult to implement from a techni-
cal point of view, it was totally different regarding the CVP experiment. After 
selection of this experiment, many managers within ESA and NASA thought it 
would be impossible to be allowed to conduct such an invasive study. We succeeded 
anyway, which was because of one important thing: the backing of the appointed 
payload commander. Without this support for the experiment, it would never have 
been executed. The reason for the astronaut support was because of thrust in our 
research group’s ability to conduct the study, which we obtained by always being 
well prepared for pre-flight briefings of the astronauts as well as for the pre-flight 
control studies. We always made sure that as much of the data that had been col-
lected were properly analysed between the different ground tests and that the data 
were presented to the astronauts during the subsequent tests so that they together 
with the investigators could follow the progress of the study throughout the pre-
flight period.
5.6 Execution
During the Spacelab D2 mission, I was standing in the mission control centre in 
Oberpfaffenhofen near Munich in Germany holding my breath and watching the 
big screen. All investigators followed the executions of their experiments from the 
mission control centre, and just before initiation of our renal experiment, which as 
described earlier was integrated into one complement, a valve was stuck in some of 
the equipment. If the valve problem was not solved, we would all risk that none of 
the experiments in the complement would be conducted. It was a tense moment, 
when the payload commander after directions from mission control finally got the 
valve to work and initiated the flow of measurements. What a relief!
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During execution of our urinary excretion experiment a mistake did happen, 
whereby urine bags, which were to be collected after flight directly from the trash 
can in the Space Shuttle, were not correctly labelled. It meant that we could not 
readily identify, from which crew members the urine in the bags derived. The way 
the problem of identification was solved was by measuring the concentrations of 
five different substances in each urine bag and comparing them to samples that had 
been collected inflight from each bag before trash storage. Each of the samples had 
been correctly labelled. Since each crew member had a unique pattern of concentra-
tions of the selected substances, the matching and identification of the bags with 
the samples were possible.
Spaceflight experimentation often requires creative solutions to unexpected 
problems.
The CVP experiment went well in one astronaut. Originally, we had planned 
for two astronauts to be instrumented, but unfortunately the catheter broke in one 
during an extended prelaunch period, where the catheters had been successfully 
inserted into two astronauts, but where the prelaunch period was extended for 
2 days over a weekend because of a failure in one of the shuttle’s navigation systems 
that had to be changed. During some leisure activities, it broke and was withdrawn 
before launch.
During execution of the experiment on ground before the flight, which is called 
the baseline data collection to which all inflight data were to be compared, the 
biggest obstacle occurred during the execution process of one of the pre-flight test 
sessions on the ground. The obstacle demonstrated that it is not only a challenge 
to implement and execute an experiment during the flight phase but that ground 
tests can be limiting factors too. What happened is that the gas analyser used for 
rebreathing experiments to determine cardiac output and respiratory variables 
(Figure 3) for some reason did not work. Even though these measurements were 
not directly involved with our urinary experiment, it sent our experiment to 
jeopardy, because it was totally integrated into an experimental complement to be 
executed in concert. The breakdown happened at the Aerospace Medical Institute 
at the German space centre, DLR, and since the astronauts’ test time was extremely 
limited with many other obligations, it was made clear to the experimental team 
that the astronauts would withdraw from the experiments, if the equipment was 
not working the next morning. We knew then that we were in trouble!
We were otherwise all ready to conduct the baseline data collections the next 
day, and if the gas analyser could not be fixed, it would mean that all of our experi-
mental efforts would go down the drain. What could we do?
Ingenuity, imagination and thinking out of the box are usually essential in solv-
ing unexpected problems associated with spaceflight. In fact, this is what charac-
terises this discipline. To my disappointment most of the officials and investigators 
gave up immediately. It was late afternoon, and the experiments were to be com-
menced early next morning at 07.00 am. The payload commander had left with a 
statement that he and his astronaut team would show up on time the next morning, 
and if the equipment did not work, the experimental complement would be deleted 
from the mission.
I and one of our ESA representatives soon conferred with each other, and we 
promised that we would demonstrate to the payload commander that this problem 
could be fixed in time. The only question was how? At the time we did not know 
that the problem was a burned capacitor, so we planned to have a technician imme-
diately flown down from the company, Innovision A/S, in Denmark, which had 
developed and built the equipment.
What we did was risky, unusual and not according to the normal rules and 
regulations, but we were running out of time. We had to rent a private airplane 
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Figure 3. 
This rack was called Anthrorack and developed for the spacelab D2 mission. It consisted of several pieces of 
equipment of which one was a mass spectrometer gas analyser used for respiratory analysis and cardiac output 
determinations by rebreathing (Figure 2). During the ground-based data collections, a capacitor was burned 
and had to be replaced at a very critical time before the mission.
within a few hours, because there were no commercial flights at that time. We had 
to establish an ESA guarantee for payment to the airline company, and we—above 
all—had to get in contact with the technician in Denmark. It soon turned out that he 
was available and the money for renting the airplane could be secured (after tough 
negotiations with ESA) and everything seemed possible.
The technician was late at night transported by taxi to a nearby local airport 
some 200 km away, from where he lived, entered the plane and came to Cologne 
around 4 am in the morning. We picked him up at the airport in Cologne and 
brought him to the aerospace facility, and by a miracle, he quickly identified the 
problem to be a burned capacitor and substituted it by another from a similar 
equipment.
At exactly 07.00 am before the baseline data collection was to begin, we were 
ready. The astronauts entered with the expectation that the tests would be can-
celled. We could inform them otherwise, and with a rare expression of facial rec-
ognition, the payload commander and his fellow astronauts professionally moved 
ahead to be ready for the tests.
Everything went smoothly!
This as well as the inflight incident with the stuck valve were pivotal obstacles 
for the outcome of many of the physiological experiments during the Spacelab 
D2 mission. Had they not been overcome, I would probably not have been able to 
continue my space physiology career for the next 30 years.
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5.7 Data analysis
It is pivotal to make sure that the data collected are correct. One basic rule is for 
the principal investigator to always be present or to have proper representation at 
each of the pre- and post-flight experimental sessions and to be monitoring how 
the data collections are done during flight—preferably from a mission control 
centre. If that is not made sure of by the investigators of a study, one cannot be 
sure that the circumstances surrounding the collections are fully understood and 
that handling of blood samples is done correctly and according to specifications. 
Furthermore, the investigators have to make sure to be readily available during 
executions of their experiment should inquiries from space agency representatives 
need acute responses and interventions. Otherwise, it is unlikely that the data can 
be trusted.
The investigators must also be proactive and tenacious in obtaining the 
 collected data in space that usually are stored on inflight computers. One way to 
make sure that the data are correctly handled is to push the mission controllers 
to download as much as possible from space to ground as soon as the data are 
collected, because no one knows what could happen afterwards to the storage. 
Usually, it is not a problem should downloading not be possible, but in this case, it 
can also delay the post-flight analysis of the data because of bureaucratic impedi-
ments to obtain it.
During the very sad and unfortunate accident of the STS-107 mission on 
February 1, 2003, where the Space Shuttle, Columbia, and crew were lost during 
re-entry in the atmosphere, I was in charge of an experiment. We conducted inflight 
cardiac output rebreathing experiments as well as blood pressure monitoring. The 
data were downloaded to the mission control centre during the mission, which 
made it possible for us to publish the data so that the experiments—despite the very 
sad circumstances—were not done in vain.
During the Euromir 95 mission, which was a long-duration mission on the 
Russian space station Mir, where the ESA astronaut, Thomas Reiter, stayed for 
179 days in space, I was in charge of a urinary collection experiment following an 
oral water load. I obtained the inflight data directly from Thomas Reiter himself 
shortly after his flight, which is unusual, but we did so to bypass the bureaucracy. 
Otherwise it could have taken weeks to obtain it.
5.8 Publication
The most important part of all investigations including those in conjunction 
with human spaceflights is to publish the results in as widely distributed scientific 
journals as possible. The whole purpose of obtaining the data is to gain new knowl-
edge, and by publishing in science journals with external peer review, there is a 
certain guarantee for data quality and interpretation. It usually takes 2 years after 
the end of a spaceflight mission to have the data published, but many times, it takes 
longer. The investigators, however, owe it to everybody involved as well as society in 
general to produce a scientific publication as fast as possible.
From the Spacelab D2 mission in 1993, our research team succeeded in pub-
lishing three papers within 3 years of the mission [1–3]. During later missions 
on the Russian space station Mir, the Space Shuttle Columbia (STS-107) and the 
International Space Station, we conducted five additional experiments focusing 
on how the human cardiovascular system adapts to short- and long-duration 
flights [6–10]. This is important for understanding the long-duration health 
effects of future deep space missions that may last up to 3 years on a mission 
to Mars.
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6. Parabolic flights
In preparation of the CVP experiment for the Spacelab D2 mission, we in 1991 
participated in a series of ESA-funded parabolic flights at an air base in Bretigny-
sur-Orge, near Paris in France. The purpose of participating in these flights was not 
only to test the technical feasibility of the equipment in weightlessness but also to 
obtain short-term data during this condition and compare them to longer effects 
of spaceflight (see Figure 4). At that time, the parabolic flights were conducted 
by a Caravelle, which flew in a Keplerian trajectory, thereby creating a free fall 
condition (0 g) symmetrically around the top of the trajectory for 20 s. Some 20 s 
before and after the 0 g period, the plane underwent a period of increased g’s from 
1 up to 2. Thus, it is a very short period of weightlessness that is created in this way, 
but it is the only way to induce real weightlessness in humans without going into 
actual space.
The CVP equipment was also tested during longer weightless periods (some 
60 s) in a fighter airplane (Draken) in Denmark in one of the investigators. This test 
was supported by the Royal Danish Air Force. All of these tests were conducted in 
seven subjects (Caravelle) and in an additional one subject (Draken) and demon-
strated that the equipment worked during short-term variations in g’s between 0 
and 4. In addition we obtained data on effects of short-term changes in g-loads on 
CVP including effects of weightlessness for comparisons with spaceflight.
For further interpretation of the data, we later after completion of the D2 
mission performed another series of CVP experiments during 20 s of weightless-
ness during parabolic flights [11]. In that context, we added measurements of 
oesophageal pressures through an air tube that was swallowed by the test subject 
Figure 4. 
Dr. Regitze Videbaek measuring the size of the heart chambers in a subject during an ESA parabolic flight 
campaign. The airplane ascents into a parabolic (Keplerian) trajectory to create weightlessness for 20 s. The 
subject is also instrumented with invasive monitoring equipment for estimating central venous pressure (CVP), 
which was also used for the D2 spacelab mission in 1993 on board the space shuttle Columbia [3].
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through the nose for obtaining intrathoracic pressures. Intrathoracic pressures are 
the pressures surrounding the heart. Those pressures were not measured during the 
Spacelab D2 mission, so the parabolic flight data helped us interpret the CVP data 
from space.
The process of getting access to parabolic flights is not very different from 
getting access to spaceflight. Investigators must usually respond to solicitations put 
forward by a space agency and go through the scientific selection and feasibility 
assessment processes. The space agency will supply the investigators with the infra-
structure such as the flights, but investigators must find their own funding, which 
usually also applies for adjustments of the equipment to fit into the airplane. In 
some cases, investigators will have more direct access to the parabolic flight venue, 
if their experiments concern technical feasibility assessments for a spaceflight. 
Obtaining experimental baseline data from these flights for comparisons with space 
data can also be allowed at the discretion of the relevant space agency.
7. Results and conclusions
7.1 Spacelab D2 mission
From the Spacelab D2 mission, our CVP and urinary experiments showed us a 
new mechanism as to how blood and fluid are shifted from the lower to the upper 
portions of the body in weightlessness and that the excretion rate of a saline load 
is not faster than on Earth. Both results were surprising and revealed new insight. 
Likewise, it was a surprise that the agitating (sympathetic) part of the autonomous 
nervous system was stimulated during weightlessness and that it was not—as 
expected—supressed. In ground-based simulation studies using 60 head-down bed 
rest or acute seated head-out water immersion, the opposite is usually seen. Thus, 
there is a difference in effects of weightlessness in space and the simulation models 
on the ground.
Despite the upward blood shift to the heart and head, CVP was measured 
to decrease in space compared to being horizontal supine on the ground (see 
Figure 5). We had expected it to be increased. The data we obtained were only from 
one astronaut, but a US-led team during two other missions also measured CVP 
directly with invasive catheters and found decreases. We thereafter performed a 
parabolic flight study and measured CVP with same technology as during the D2 
mission and found similar acute decreases during the 20 s of weightlessness [11]. 
However, we also observed that the heart was expanded despite the decreased CVP, 
because simultaneously the oesophageal pressure also decreased and even more so. 
From ultrasound images taken of the heart during the parabolic weightless period, 
we observed an expansion of the cardiac chambers, so the ostensible discrepancy 
between the decrease in CVP and the expanded heart could be reconciled by the 
expansion of the thorax that further stretches the heart and gives an erroneous 
impression of the change in its feeding pressure (CVP, Figure 6).
7.2 Subsequent space missions
From our later inflight experiments [6–10] following the Spacelab D2 mission, 
the main conclusions can be briefly summarised as follows:
• Cardiac output and stroke volume increase by some 35–40% during months 
of flight in space, which is caused by the weightlessness-induced upward 
fluid shift.
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• The arterial resistance vessels dilate and decrease the circulatory resistance by 
some 40% and blood pressure by 10 mm Hg.
• The sympathetic nervous activity is not decreased in space and is at the level of 
being upright on ground, which is supported by the attenuated urinary excre-
tion rates of fluid and sodium.
• The dilatation of the arteries and the high sympathetic nervous  activity 
is in contradiction to each other, and the mechanism is not yet known 
(Figure 7).
Figure 6. 
The parabolic flight experiment which helped us interpret the Spacelab D2 mission data. Central venous 
pressure (CVP) was measured directly with long catheters with transducers at their tip placed near to the heart 
chambers in supine subjects during the parabolic manoeuvre. Simultaneously, the intrathoracic pressures (IPP) 
were also measured through long air-filled tubes with balloons at the end in the oesophagus. By subtracting 
IPP from CVP, the transmural heart distension pressure (tCVP) can be estimated. As can be seen, the tCVP 
increased in weightlessness (0 G) by 4.3 mm Hg (Delta) even though CVP fell by 1.3. Thus, parabolic flight 
data could help interpret those obtained during spaceflight [3, 11].
Figure 5. 
Central venous pressure (in mm Hg) as a function of time in one astronaut before launch of the space shuttle 
in the suit room with the space suit on and in the shuttle on the launch pad in the supine leg-up position. 
(A) Closing of the helmet visor. (B) ignition. (C) Release of the solid rocket boosters from the ascending shuttle. 
(D) Entering weightlessness. The g-load (G) is indicated at the bottom [3].
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Thus, to our experience, experiments in space have revealed some new insight 
and mechanisms into human physiology, which could be of importance in inter-
preting the health consequences of long-duration flights in the future. By compar-
ing the effects of long-duration (3–6 months) spaceflight on the International 
Space Station [12] with those of short-term shuttle flights [8], there are at least two 
important and surprising observations: (1) The shift of blood and fluid from the 
lower body segments into the heart, which increases cardiac output, is even bigger, 
and (2) blood pressure is more decreased by a more pronounced peripheral vasodi-
lation (Figures 6 and 7).
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Figure 7. 
During missions to the international Space Station in the period of 2006 to 2012, we conducted measurements 
of cardiac output by a non-invasive rebreathing method in eight astronauts and found a clear-cut increase in 
some 35% between the 3rd and 6th month in space [10]. At the same time, blood pressure is decreased, which 
indicates that the total vascular resistance is decreased by almost 40%. In contradiction to this, noradrenaline 
levels are not suppressed but maintained unchanged from ground-based upright levels. Thus, the mechanism of 
chronic peripheral vasodilatation in space is still unknown [10, 12].
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